Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An announcement from Elite Pharmaceuticals ( (ELTP) ) is now available.
Elite Pharmaceuticals has launched a generic version of Norco®, a prominent pain management drug, potentially tapping into a lucrative market with reported annual sales of $300 million. This move underscores Elite’s strategy to focus on niche generic products, leveraging its specialized manufacturing facilities in New Jersey to produce both immediate and controlled-release oral dose medications.
For a thorough assessment of ELTP stock, go to TipRanks’ Stock Analysis page.
